- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05991141
Could Apnea Induce Hypoalgesia?
August 11, 2023 updated by: José Fierro Marrero, Centro Universitario La Salle
Could Apnea Induce Hypoalgesia? An Explorative Randomized Controlled Trial
A randomized controlled trial (RCT) in healthy subjects will be conducted with the following aims: (1) Explore the effect of low pulmonary volume dynamic apnoea bouts on Pressure Pain Threshold (PPT) and conditioned pain modulation (CPM); (2) analyse whether CPM response correlates with apnoea induced hypoalgesia; (3) examine the association between apnoea bouts, Rate of Perceived Exertion, hypoxemia and Heart Rate changes in PPT.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
A randomized controlled trial (RCT) in healthy subjects will be conducted with the following aims: (1) Explore the effect of low pulmonary volume dynamic apnoea bouts on Pressure Pain Threshold (PPT) and conditioned pain modulation (CPM); (2) analyse whether CPM response correlates with apnoea induced hypoalgesia; (3) examine the association between apnoea bouts Rate of Perceived Exertion, hypoxemia and Heart Rate changes in PPT
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28023
- Centro Superior de Estudios La Salle
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy participants
- 18-30 years
- Currently pain-free
- Basal SpO2 ≥95%
Exclusion Criteria:
- Diabetes diagnosis
- Hypertension or hypotension diagnosis
- Pharmacological treatment
- Frequent pain during last month
- Drug consumption
- Self-harming behaviours
- Pregnant or potentially pregnant
- Cardiac or respiratory pathology
- Splenectomy or spleen disease
- Having performed moderate or high intensity physical activity 24 hours prior to the study
- Not having slept the previous night
- Alcohol intake 24 hours prior to study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Group
|
In both experimental and control groups participants walked on a treadmill at 5.5 km/h with 5º inclination for 6 minutes.
The experimental group (EG) added throughout the 6 minutes intervention the following breathing pattern cyclically: 5 seconds breathing normally followed by 10 seconds of low volume apnoea, performing a total of 24 cycles of normal breathing continued by apnoea.
|
|
Sham Comparator: Control Group
|
In both experimental and control groups participants walked on a treadmill at 5.5 km/h with 5º inclination for 6 minutes.
The Control group (CG) performed this protocol breathing normally.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure Pain Threshold
Time Frame: Before and immediately after the interventions
|
PPT refers to the minimal amount of pressure needed to cause the first sensation of pain.
The mechanical pressure algometer (PAIN TEST™ FPX 25, Wagner Instruments, Greenwich, CT, USA) counted with a round rubber disc of 1 cm2, displaying values in Kg, hence, data was expressed in Kg/cm2.
Two locations, in upper and lower limbs, were examined to examine systemic hypoalgesia effects.
The dorsal distal-phalange base of the thumb and tibialis anterior muscle belly, both in the dominant limb, were tested.
These regions were marked with a pen before assessments, to repeat the trials in the same place.
Three trials were tested in each location, with 30 seconds rest between trials.
Pressure speed was paced with a metronome applying a constant force of 0.5 Kg/cm2/s ± 0.1 Kg/cm2/s.
|
Before and immediately after the interventions
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Conditioned pain modulation
Time Frame: Before and immediately after the interventions
|
Conditioning stimulus was applied on the contralateral limb to test stimulus, since its arrangement does not influence CPM response.
Only controversial CPM response have appeared when tests and conditioned stimuli were applied on the same body region.
Ischemic pain was applied as conditioning stimulus and PPT as test stimulus.
Ischemic pain was provoked inflating a sphygmomanometer at the proximal region of the non-dominant arm.
When inflated up to 180-200 mmHg patients were asked to actively move fingers and wrist.
They were asketd to report when a 7/10 pain in Numerical Pain Rating Scale (NPRS) scale was reached.
In that moment, three trials of test stimuli were applied on the dorsal distal-phalange base of the thumb in the dominant arm, while maintaining the ischemic pain perception.
|
Before and immediately after the interventions
|
|
Heart Rate and Oxygen Saturation
Time Frame: During the intervention and for 2 minutes additionally after the end of the intervention
|
We video-taped HR and SpO2 values during the 6 min interventions and 2 minutes afterwards to explore their changes during and after interventions.
HR and SpO2 data were extracted in each second.
These values would be graphically displayed.
Peak %HRmax and minimum SpO2, and means of both variables, value would be extracted from the 6-minute interventions.
HR zones or exercise-induced hypoxemia zones were also recorded.
|
During the intervention and for 2 minutes additionally after the end of the intervention
|
|
Rated Perceived Exertion
Time Frame: This outcome was assessed immediately after having finished the intervention protocols
|
Apnea and control interventions were explored in terms of Rated Perceived Exertion in with Borg's modified CR-10
|
This outcome was assessed immediately after having finished the intervention protocols
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: José Fierro Marrero, CSEULaSalle
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2023
Primary Completion (Actual)
May 15, 2023
Study Completion (Actual)
May 15, 2023
Study Registration Dates
First Submitted
July 26, 2023
First Submitted That Met QC Criteria
August 11, 2023
First Posted (Actual)
August 14, 2023
Study Record Updates
Last Update Posted (Actual)
August 14, 2023
Last Update Submitted That Met QC Criteria
August 11, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CSEULS-PI-029/2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
Clinical Trials on Apnea
-
Poitiers University HospitalCompletedAlternative Method of Apnea TestFrance
-
Centre Hospitalier Universitaire VaudoisUnknownObstructive Sleep Apnea | End Stage Renal DiseaseSwitzerland
-
Poitiers University HospitalCompletedAlternative Method of Apnea TestFrance
-
Weill Medical College of Cornell UniversityNorthwell Health; The Methodist Hospital Research InstituteCompleted
-
University Hospital, MontpellierCompletedRecent Acute Myocardial InfarctionFrance
-
Herlev and Gentofte HospitalRecruitingSleep Apnea | Atrial Fibrillation (AF)Denmark
-
Taipei Veterans General Hospital, TaiwanMinistry of Science and Technology, TaiwanNot yet recruiting
-
Fisher and Paykel HealthcareCompleted
-
CIDELECNot yet recruitingSleep Apnea (Disorder)
-
Karolinska University HospitalUmeå University; Uppsala University Hospital; Sunderbyn Hospital; Stockholm Heart...CompletedObstructive Sleep ApneaSweden